Better than nothing: keeping pts on failing regimen has benefits.
In a retrospective study of HIV-infected patients, those with CD4+ lymphocyte count 50-200, and < 50 who had detectable HIV RNA levels on combination antiretroviral therapy (cART), a 34% and 22% reduction, respectively, in new AIDS-defining events (ADE) was observed in patients who continued cART compared to patients who stopped cART.